Don't ignore PSTI's PLX-PAD, they've had excellent results with compassionate use patients, their trial has recently begun, but shouldn't take that long to run. Their biggest advantage is getting 20,000 doses from a single placenta.
I believe their 3-D bioreactor is superior to anything else available for producing their products.